Tackling Alzheimer's Too Late

Contributed by: Dennis Fortier, President, Medical Care Corporation

The expert consensus on this is growing stronger every day: we are intervening against Alzheimer's disease far too late.

This perspective has been long acknowledged in clinical circles, where physicians first treat Alzheimer's patients an average of about 8 years after the onset of subtle symptoms. But recently, it has gained rapid momentum in research circles as well.

With the recent, high-profile failure of another AD drug in the FDA pipeline, the research community is increasingly concluding that, the inefficacy of the drugs may be due, in part, to the fact that we are testing them on patients in whom the disease is too advanced. It does stand to reason that, once a brain cell is dead, no drug will bring it back to life.

As reported by The Telegraph, an editorial in this months issue of The Lancet summarizes this emerging viewpoint with clarity.
A better understanding and more awareness of Alzheimer's related issues can impact personal health decisions and generate significant impact across a population of aging individuals. Please use the share buttons below to spread this educational message as widely as possible.

No comments :

Post a Comment